Measurement and Management of QT Interval Prolongation for General Physicians

被引:29
作者
Indraratna, Praveen [1 ,2 ,3 ]
Tardo, Daniel [4 ,5 ]
Delves, Madeline [6 ]
Szirt, Richard [2 ]
Ng, Ben [1 ,3 ]
机构
[1] Prince Wales Hosp, Dept Cardiol, Sydney, NSW 2031, Australia
[2] St George Hosp, Dept Cardiol, Sydney, NSW, Australia
[3] Univ New South Wales, Fac Med, Sydney, NSW, Australia
[4] St Vincents Hosp, Dept Med, Sydney, NSW, Australia
[5] Univ Notre Dame, Sch Med, Sydney, NSW, Australia
[6] Bloomfield Hosp, Dept Psychiat, Orange, NSW, Australia
关键词
torsades de pointes; QT interval; electrocardiogram; antipsychotics; antiarrhythmics; TORSADES-DE-POINTES; CLINICAL-PRACTICE GUIDELINES; NEW-ZEALAND COLLEGE; LONG-QT; RISK-ASSESSMENT; ECG ANALYSIS; HEART-RATE; CLARITHROMYCIN; SCHIZOPHRENIA; LEVOFLOXACIN;
D O I
10.1007/s11606-019-05477-7
中图分类号
R19 [保健组织与事业(卫生事业管理)];
学科分类号
摘要
One of the more challenging aspects of ECG interpretation is measurement and interpretation of the QT interval. This interval represents the time taken for the ventricles to completely repolarise after activation. Abnormal prolongation of the QT interval can lead to torsades de pointes, a form of potentially life-threatening polymorphic ventricular tachycardia (VT). Detection of a prolonged QT interval is essential as this can be a reversible problem, particularly in the context of the use of a variety of commonly prescribed medications in the hospital setting. Automated ECG printouts cannot be relied upon to diagnose QT interval prolongation; thus, the onus is on the clinician to identify it. This is a difficult task, as the normal QT interval is typically measured relative to the heart rate. Therefore, the QT interval often requires "correction" for the current heart rate, in order to correctly stratify the risk of torsades de pointes. A wealth of correctional formulae have been derived, but none has proven superior. We present an approach to the ECG in this context, and a step-by-step guide to manually measuring and correcting the QT interval, and an approach to management in common hospital-based clinical scenarios.
引用
收藏
页码:865 / 873
页数:9
相关论文
共 55 条
[1]  
[Anonymous], 2015, ETG COMPL THER GUID
[2]  
[Anonymous], 2019, QTDRUGS LIST
[3]   QT Prolongation, Torsades de Pointes, and Psychotropic Medications: A 5-Year Update [J].
Beach, Scott R. ;
Celano, Christopher M. ;
Sugrue, Alan M. ;
Adams, Caitlin ;
Ackerman, Michael J. ;
Noseworthy, Peter A. ;
Huffman, Jeff C. .
PSYCHOSOMATICS, 2018, 59 (02) :105-122
[4]   The Half RR Rule: A Poor Rule of Thumb and Not a Risk Assessment Tool for QT Interval Prolongation [J].
Berling, Ingrid ;
Isbister, Geoffrey K. .
ACADEMIC EMERGENCY MEDICINE, 2015, 22 (10) :1139-1144
[5]   QT Prolongation and Torsade de Pointes Induced by Fluoroquinolones: Infrequent Side Effects from Commonly Used Medications [J].
Briasoulis, Alexandros ;
Agarwal, Vikram ;
Pierce, Walter J. .
CARDIOLOGY, 2011, 120 (02) :103-110
[6]   Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram [J].
Chan, A. ;
Isbister, G. K. ;
Kirkpatrick, C. M. J. ;
Dufful, S. B. .
QJM-AN INTERNATIONAL JOURNAL OF MEDICINE, 2007, 100 (10) :609-615
[7]   QT Interval Prolongation Associated With Cytotoxic and Targeted Cancer Therapeutics [J].
Chandrasekhar, Sanjay ;
Fradley, Michael G. .
CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2019, 20 (07)
[8]   Clarithromycin-Induced Torsades de Pointes [J].
Chang, Nai-Lun ;
Shah, Priyank ;
Bikkina, Mahesh ;
Shamoon, Fayez .
AMERICAN JOURNAL OF THERAPEUTICS, 2016, 23 (03) :e955-e956
[9]   Risk Evaluation of Azithromycin-Induced QT Prolongation in Real-World Practice [J].
Choi, Young ;
Lim, Hong-Seok ;
Chung, Dahee ;
Choi, Jung-gu ;
Yoon, Dukyong .
BIOMED RESEARCH INTERNATIONAL, 2018, 2018
[10]  
Drew BJ, 2010, J AM COLL CARDIOL, V55, P934, DOI [10.1016/j.jacc.2010.01.001, 10.1161/CIRCULATIONAHA.109.192704]